Inventaire - your friends and communities are your best library - Inventaire

Pharmacogenetics - five decades of therapeutic lessons from genetic diversity

published in: Nature Reviews Genetics

date of publication: 2004-09-01

language: English

main subject: genetic diversity

Bibliographic databases:

Cites articles 38

Date

Title

Authors

1932-01-01

The Relationship between Chemical Constitution and Taste
1952-08-01

Toxicity of primaquine in Caucasians
1956-09-14

Enzymatic Deficiency in Primaquine-Sensitive Erythrocytes
1956-07-01

The familial incidence of low pseudocholinesterase level
1957-10-01

Drug reactions enzymes, and biochemical genetics
1960-08-01

Genetic control of isoniazid metabolism in man
1969-12-01

Steady-state plasma levels of nortriptyline in twins: influence of genetic factors and drug therapy
1977-09-01

Polymorphic hydroxylation of Debrisoquine in man.
1979-09-01

Defective N-oxidation of sparteine in man: a new pharmacogenetic defect,Defective N-oxidation of sparteine in man: A new pharmacogenetic defect
1982-05-01

Assay and characterisation of debrisoquine 4-hydroxylase activity of microsomal fractions of human liver
1984-08-01

Debrisoquine-type polymorphism of drug oxidation: purification from human liver of a cytochrome P450 isozyme with high activity for bufuralol hydroxylation
1984-01-01

Pharmacogenetics of mephenytoin: a new drug hydroxylation polymorphism in man
1988-02-01

Characterization of the common genetic defect in humans deficient in debrisoquine metabolism
1988-11-01

Antibodies against human cytochrome P-450db1 in autoimmune hepatitis type II.
1988-07-01

Two mutant alleles of the human cytochrome P-450db1 gene (P450C2D1) associated with genetically deficient metabolism of debrisoquine and other drugs
1990-10-01

Identification of the primary gene defect at the cytochrome P450 CYP2D locus
1990-09-01

Genotyping of poor metabolisers of debrisoquine by allele-specific PCR amplification
1991-06-01

Molecular mechanism of slow acetylation of drugs and carcinogens in humans
1991-07-01

Diverse point mutations in the human gene for polymorphic N-acetyltransferase
1993-12-15

Inherited amplification of an active gene in the cytochrome P450 CYP2D locus as a cause of ultrarapid metabolism of debrisoquine
1993-01-01

Molecular basis for rational megaprescribing in ultrarapid hydroxylators of debrisoquine
1995-02

Nomenclature for N-acetyltransferases

, ,
1997-01-01

Molecular mechanisms of genetic polymorphisms of drug metabolism
1999-04-01

As consortium plans free SNP map of human genome
2000-04-01

Extension of a pilot study: impact from the cytochrome P450 2D6 polymorphism on outcome and costs associated with severe mental illness
2000-11-01

Pharmacogenetics and adverse drug reactions
2002

The incidence of alkaptonuria: a study in chemical individuality. 1902 [classical article]
2002-01-01

The genetic basis of variability in drug responses
2003-02-01

Pharmacogenomics--drug disposition, drug targets, and side effects
2003-06-01

Decreasing smoking behaviour and risk through CYP2A6 inhibition

,
2003-11-15

Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry
2003-02-01

Inheritance and drug response

Article -

Welcome to inventaire

The library of your friends and communities

you are offline